ArticlePloS one2016

Myoinositol as a Biomarker in Recurrent Glioblastoma Treated with Bevacizumab: A 1H-Magnetic Resonance Spectroscopy Study.

Eike Steidl et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.